| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |